lee_m2020 , by this time round you have seen how the operator played. It would not go back to 0.410 .. If yes I wanna unload now and then wait. But am I going to do that. the answers is no no no.
IRIS has been trading above its upward sloping 20-Day Moving Average which is a good sign. The support and resistance level of IRIS are 0.425 and 0.45 respectively. The indicator analysis on RSI is not exhibiting any extreme condition. Watch out for the 30% and 70% levels which indicate any oversold and overbought condition respectively.
MyEG Services Bhd, which has inked a deal with China’s Anhui Zhifei Longcom Biopharmaceutical Co Ltd (Zhifei) to supply its vaccine, believes the government will also secure supplies from the private sector.
As for MyEG, Wong notes that the price of its vaccines will depend on volume, but it will still be competitive.
The company has been engaging with the Ministry of Health and relevant authorities on its planned distribution.
Under the deal with Zhifei, MyEG has the exclusive rights for the distribution of the vaccine in Malaysia for a three-year period.
Zhifei — a subsidiary of Chongqing Zhifei Biological Products Co Ltd, which is listed on the Shenzhen Stock Exchange — is one of five Chinese companies conducting Phase 3 clinical trials. Zhifei has enjoyed a 200% jump in its share price year to date.
MyEG’s share price surged to a high of RM2.19 on Dec 7 and has gained 80.9% year to date.
MyEG says it will complete local Phase 3 clinical trials under the supervision of Clinical Research Malaysia (CRM) to ensure that the vaccine is safe and meets the efficacy requirements for the country’s population of 33 million.
“We intend to strengthen the competencies of our team by bringing on board, where necessary, people with the right experience, expertise and skill sets along different stages of the journey.
“We are ready to start and are engaging CRM and a clinical research organisation to finalise the timeline.”
For My EG Services Bhd (MyEG), investors may have to ignore the noises and focus on contracts that it has in hand, which will be a reflection of its earnings potential.
Despite the evolving political landscape, many of MyEG's e-government contracts have been renewed. Not just that, the company has also been given new contracts, for instance to operate the MySafeTravel for the Ministry of Health, which is a digital health pass system for incoming travellers from abroad.
It also runs a portal to help companies arrange for the subsidised Covid-19 tests for staff, both local and foreign. The company has carried out roughly 200,00 Covid-19 test screenings since the service was launched at end-June 2020 until October 2020.
It also offers new services for the Road Transport Department, such as online renewal of motorcycle insurance, road tax and driver's licence.
MyEG also made headlines for acquiring a 10% stake in S5 Holdings Inc, which was a contender for the RM1.8 billion National Integrated Immigration System contract. Subsequently, shareholders of S5 decided to seek a backdoor listing through Ancom Logistics Bhd.
MyEG is seen to be a victim of the changing political landscape. That said, given that its existing contracts with government agencies have been renewed, and new jobs granted, the company could be a counter to look out for in 2021.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
rayhvs
159 posts
Posted by rayhvs > 2020-12-31 15:32 | Report Abuse
fly kite